These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6433466)

  • 1. The development of blood coagulation laboratory facilities in China and their use in hemophilia.
    Zhen-Yi W; Zhu C; Shao HZ; Hong-Li W
    Scand J Haematol Suppl; 1984; 40():451-4. PubMed ID: 6433466
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of factors VIII:C and VIIIR:Ag in the detection of classic hemophilia. Study of 40 cases].
    Ambríz-Fernández R; Reyna-Fregoso MP; Cruz ML; Avilés A; García MA; Morales MR; Pizzuto J
    Rev Invest Clin; 1984; 36(3):257-63. PubMed ID: 6440253
    [No Abstract]   [Full Text] [Related]  

  • 3. Performance characteristics of a commercial kit for assay of factor viii-related antigen.
    Cejka J
    Clin Chem; 1984 May; 30(5):814-5. PubMed ID: 6424967
    [No Abstract]   [Full Text] [Related]  

  • 4. [Processing data for predicting hemophilia transmission].
    Sikorová J; Zvárová J; Paluska E; Vorlová Z
    Vnitr Lek; 1984 Aug; 30(8):764-70. PubMed ID: 6438902
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of hemophilia carriers during pregnancy.
    Hoyer LW; Carta CA; Mahoney MJ
    Blood; 1982 Dec; 60(6):1407-10. PubMed ID: 6814553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VIII/von Willebrand factor.
    Zimmerman TS; Ruggeri ZM; Fulcher CA
    Prog Hematol; 1983; 13():279-309. PubMed ID: 6422506
    [No Abstract]   [Full Text] [Related]  

  • 7. Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. A study of the cooperative group of hemophilia.
    Ambriz-Fernández R; Reyna-Fregoso MP; Pizzuto-Chávez J; Rodríguez-Moyado H; Farfán-Canto JM; Trueba-Christy E; Collazo-Jaloma J
    Arch Invest Med (Mex); 1985; 16(3):225-35. PubMed ID: 3938639
    [No Abstract]   [Full Text] [Related]  

  • 8. The combined use of monoclonal antibody-based enzyme-linked immunosorbent assays (ELISA) for factor VIII antigen (VIII:Ag) and von Willebrand factor antigen (vWF:Ag) for the detection of carriers of haemophilia A.
    Furlong RA; Chesham J; Peake IR
    Clin Lab Haematol; 1988; 10(3):295-305. PubMed ID: 3141105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A.
    Labarque V; Perinparajah V; Bouskill V; Stain AM; Wakefield C; Manuel C; Blanchette VS; James PD; Lillicrap D; Carcao MD
    Am J Hematol; 2017 Jun; 92(6):E94-E96. PubMed ID: 28249352
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multimeric composition of factor VIII-related protein following DDAVP infusion in normal subjects and patients with hemophilia A and von Willebrand's disease].
    Takase T; Nishino M; Yasui M; Shima M; Yoshikawa N; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1985 Nov; 48(7):1571-8. PubMed ID: 3937410
    [No Abstract]   [Full Text] [Related]  

  • 11. Factor VIII related activities in concentrates.
    Nilsson IM; Borge L; Gunnarsson M; Kristoffersson AC
    Scand J Haematol Suppl; 1984; 41():157-72. PubMed ID: 6440282
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of factor VIII antigen (VIIIR-Ag) by erythrocyte agglutination].
    Coelho E
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(6):273-6. PubMed ID: 3138751
    [No Abstract]   [Full Text] [Related]  

  • 13. Carriers and noncarriers of haemophilia A: I. Multivariate analysis of pedigree data, screening blood coagulation tests and factor VIII variables.
    Wahlberg T; Blombäck M; Brodin U
    Thromb Res; 1982 Mar; 25(5):401-14. PubMed ID: 6803389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in the hereditary patterns of factor VIII complex in a large kindred: coexistence of hemophilia A with Von Willebrand.
    Tavori S; Tatarsky I
    Am J Hematol; 1984 Jul; 17(1):1-9. PubMed ID: 6430067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier detection in haemophilia a by immunological measurement of factor VIII related antigen (VIIIRAg) and factor VIII clotting antigen (VIIICAg).
    Peake IR; Newcombe RG; Davies BL; Furlong RA; Ludlam CA; Bloom AL
    Br J Haematol; 1981 Aug; 48(4):651-60. PubMed ID: 6791679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics of factor VIII and its disorders.
    Bloom AL; Peake IR
    Semin Hematol; 1977 Jul; 14(3):319-39. PubMed ID: 327558
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of high molecular weight factor VIII on the measurement of low molecular weight factor VIII procoagulant in different assay systems.
    Muntean W; Hathaway WE; Montgomery RR
    Br J Haematol; 1982 Aug; 51(4):649-58. PubMed ID: 6809034
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of "carrier screening" of hemophilia by the ratio of factor VIII coagulant activity or antigen to factor VIII related antigen.
    Ekert H; Dean F
    Aust N Z J Med; 1983 Oct; 13(5):463-7. PubMed ID: 6418126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous inheritance and expression of classical haemophilia A and type IIA von Willebrand's disease.
    Beddall AC; Enayat SM; Williams CE; Short PE; Hill FG
    J Clin Pathol; 1984 Sep; 37(9):1035-9. PubMed ID: 6432854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular defect in hemophilia and von Willebrand's disease (author's transl)].
    Fukui H
    Rinsho Byori; 1976 Apr; 24(4):274-8. PubMed ID: 1084430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.